Buscar Close Search
Buscar Close Search
Page Menu


UMass Chan Medical School is home to unique research capabilities, including leading-edge programs in RNA therapeutics, neuroscience, host defense and precision medicine. Leading our programs are some of the world's preeminent researchers - scientists who are striving to identify and develop solutions to devastating ailments, from heart disease and diabetes to ALS and rare diseases.

The culture here is collaborative, uniting the expertise of many and providing opportunities for unique discoveries and superior outcomes. You are invited to support their efforts, and change the world of medicine. 

COVID-19/Pandemic Research Fund

COVID-19/Pandemic Research Fund

The COVID-19 pandemic has emerged as one of the greatest threats to global health in a century, stretching the world’s public health infrastructure to the breaking point. In response, UMass Chan Medical School is mobilizing its groundbreaking research platform—and our world-class researchers—to achieve rapid progress in the fight against COVID-19. This fund provides much-needed capital for real-time research activities on COVID-19 and related viruses.

Learn more


Annual Research Fund

The Annual Research Fund supports promising basic science projects through the Worcester Foundation seed grant program. These grants are awarded annually to the top 10 to 12 proposals submitted by UMass Chan Medical School scientists. Donor support has accelerated research in cancer, heart disease, ALS, Alzheimer's disease, diabetes, AIDS, multiple sclerosis, RNA interference (gene silencing) and stem cell research, and represent some of the most innovative and medically promising work being done at UMass Chan today.


Other top research areas include:

Advanced therapeutics: Gene therapy and RNA-based therapeutics

ALS and other neurological diseases

Autism/neurodevelopmental disorders



Drug resistance


Neurobiology and Neurotherapeutics

Rare diseases, including GM3, Huntington's, Tay Sachs and others


For more information:

Prescott Stewart

Executive Director of Advancement